Picton Mahoney Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15
Closed -$889 1583
2026
Q1
$889 Hold
15
﹤0.01% 1181
2025
Q4
$925 Hold
15
﹤0.01% 1140
2025
Q3
$1K Hold
15
﹤0.01% 992
2025
Q2
$1K Hold
15
﹤0.01% 883
2025
Q1
$1K Hold
15
﹤0.01% 847
2024
Q4
$1K Hold
15
﹤0.01% 764
2024
Q3
$1K Buy
+15
New +$1.06K ﹤0.01% 751
2016
Q4
Sell
-1,300
Closed -$63K 263
2016
Q3
$63K Sell
1,300
-300
-19% -$15.2K ﹤0.01% 278
2016
Q2
$89K Buy
+1,600
New +$88.1K 0.01% 249
2013
Q4
Sell
-13,600
Closed -$409K 381
2013
Q3
$409K Sell
13,600
-3,000
-18% -$98.1K 0.03% 231
2013
Q2
$484K Buy
+16,600
New +$468K 0.04% 212

Other funds holding PBH

Picton Mahoney Asset Management's PBH Position: Q2 2026 in Review

Picton Mahoney Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 15 shares — an estimated $889 sold.

Picton Mahoney Asset Management first reported a position in PBH in Q2 2013 and held it in 11 quarters. The position peaked at $484K in Q2 2013. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Picton Mahoney Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 15 Prestige Consumer Healthcare shares in Q2 2026, an estimated $889.
  • Picton Mahoney Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 11 quarters.
  • Picton Mahoney Asset Management's Prestige Consumer Healthcare position peaked at $484K in Q2 2013.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.